title: The use of low-dose methotrexate for the treatment of allograft rejection is associated with significant drug toxicity.
authors.affiliation: Loyola University Medical Center, Maywood, Ill.
authors.forename: J A
authors.initials: JA
authors.lastname: Robinson
authors.forename: M R
authors.initials: MR
authors.lastname: Costanzo-Nordin
authors.forename: B B
authors.initials: BB
authors.lastname: Grusk
authors.forename: M A
authors.initials: MA
authors.lastname: Silver
authors.forename: P A
authors.initials: PA
authors.lastname: Sobotka
authors.forename: J B
authors.initials: JB
authors.lastname: O'Connell
authors.forename: R
authors.initials: R
authors.lastname: Pifarre
mesh_terms: D001853:Bone Marrow / Q000187:drug effects; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects*; D016027:Heart Transplantation; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008727:Methotrexate / Q000008:administration & dosage* / Q000494:pharmacology / Q000633:toxicity; D013997:Time Factors
chemical_list: D008727:Methotrexate